Cart
sales@molnova.com
Beaucage reagent
CAS No. 66304-01-6
Beaucage reagent( Beaucage reagent | )
Catalog No. M15526 CAS No. 66304-01-6
A potent DNA cleavage agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 28 | In Stock |
|
| 1G | 37 | In Stock |
|
Biological Information
-
Product NameBeaucage reagent
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent DNA cleavage agent.
-
DescriptionA potent DNA cleavage agent.
-
In Vitro——
-
In Vivo——
-
SynonymsBeaucage reagent |
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number66304-01-6
-
Formula Weight200.23486
-
Molecular FormulaC7H4O3S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C1C2=CC=CC=C2S(S1)(=O)=O
-
Chemical Name3H-1,2-Benzodithiol-3-one, 1,1-dioxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zheng J, et al. Org Biomol Chem. 2010 Mar 21;8(6):1293-5.
molnova catalog
related products
-
Mithramycin A
A tricyclic pentaglycosidic, antineoplastic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA.
-
DHX9-IN-2
DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
-
Compound 3A
Compound 3A can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II.
